Andrew Greene

Andrew Greene is an accomplished executive with a strong background in strategy and business excellence, currently serving as Vice President at Edwards Lifesciences since February 2016. In this role, Andrew has contributed to the company's mission of improving patient outcomes through innovative medical solutions for structural heart disease and critical care. Prior experience includes leadership positions at Alvarez & Marsal, where Andrew focused on corporate performance improvement and operational transformation, as well as serving as a consultant at Level 11 LLC and LexisNexis, where Andrew facilitated M&A processes and managed teams to drive revenue growth. Andrew holds an MBA from UCLA Anderson School of Management and has dual degrees in International Business and German from California State University-Long Beach.